MedTrace Logo

Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients

NCT05006001 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-08-16

No results posted yet for this study

Summary

Our findings are expected to provide real-world evidence of the renal-adverse effects of colchicine and NSAIDs combination therapy in patients with gout, which will guide healthcare professions in optimizing gout treatment regimens and evaluating risks of renal impairment.

Conditions

  • Renal Impairment
  • Gout
  • Colchicine Adverse Reaction
  • Nonsteroidals (NSAIDs)Toxicity

Interventions

DRUG

Colchicine and NSAID

Colchicine and nonsteroidal anti-inflammatory drug combination therapy

Sponsors & Collaborators

  • En Chu Kong Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2019-12-31
Completion
2024-12-31
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006001 on ClinicalTrials.gov